Director, Technical Accounting & SEC Reporting

Why join Freenome?

Freenome is a high-growth biotech company developing tests to detect cancer using a standard blood draw. To do this, Freenome uses a multiomics platform that combines tumor and non-tumor signals with machine learning to find cancer in its earliest, most-treatable stages. 

Cancer is relentless. This is why Freenome is building the clinical, economic, and operational evidence to drive cancer screening and save lives. Our first screening test is for colorectal cancer (CRC) and advanced adenomas, and it’s just the beginning. 

Founded in 2014, Freenome has ~500 employees and more than $1.1B in funding from key investors, such as the American Cancer Society, Andreessen Horowitz, Anthem Blue Cross, Bain Capital, Colorectal Cancer Alliance, DCVC, Fidelity, Google Ventures, Kaiser Permanente, Novartis, Perceptive Advisors, RA Capital, Roche, Sands Capital, T. Rowe Price, and Verily.  

At Freenome, we aim to impact patients by empowering everyone to prevent, detect, and treat their disease. This, together with our high-performing culture of respect and cross-collaboration, is what motivates us to make every day count. 

Become a Freenomer

Do you have what it takes to be a Freenomer? A “Freenomer” is a determined, mission-driven, results-oriented employee fueled by the opportunity to change the landscape of cancer and make a positive impact on patients’ lives. Freenomers bring their diverse experience, expertise, and personal perspective to solve problems and push to achieve what’s possible, one breakthrough at a time.

About this opportunity:

The Director, Technical Accounting & SEC Reporting will define and build Freenome’s Technical Accounting applications and disclosures in advance of commercial operations and public status. This will include adopting accounting policies and guidelines, leading SOX compliance, preparation of SEC filings, participating as a key contributor to financial reports and filings, and providing practical direction for the organization in the areas of technical and complex accounting policies and transactions. The ideal candidate has deep Life Science technical accounting experience, is known as a solutions-oriented cross-functional partner and will have a significant impact on the continued growth of an organization dedicated to changing the entire landscape of cancer.

What you’ll do:

• Ownership and accountability for all policies and processes related to technical accounting, SEC reporting, and defined aspects of month-end close
• Evaluate and continually improve accounting procedures, processes, and systems to ensure standardized close processes and efficient operations
• Responsible for implementing and evaluating internal controls within financial reporting and consolidation
• Lead the technical accounting and SEC reporting functions, ensuring compliance and accurate presentation of financial statements and disclosures in accordance with U.S. GAAP and SEC rules
• Lead the preparation of monthly, quarterly and annual internal financial statements as well as S-1, 10-Q, 10-K, and any other SEC required filings including footnote preparation
• Manage SOX 404 implementation and ensure reporting requirements related to the Sarbanes-Oxley Act are met
• Research and evaluate complex accounting transactions and provide guidance on the appropriate accounting treatment
• Support data-driven financial analyses for future research and development investments with input to R&D, Commercial, and FP&A stakeholders
• Stay abreast of changes to accounting standards and implement new or revised processes and procedures to ensure compliance
• Analyze peer company filings and industry reports to assess trends in financial disclosures
• Determine and manage timelines for financial statement preparation and filing and work collaboratively with various business partners to ensure timelines are met
• Prepare presentations for the Audit Committee and senior leadership on an array of financial topics
• Assist with the preparation of the quarterly earnings release and related documents
• Review assumptions used to calculate stock-based compensation
• Support internal and external audits and regulatory examinations
• Where applicable, support M&A due diligence efforts, including planning, due diligence review, technical accounting position, opening balance sheet, purchase price allocation and finance integration planning

Must haves:

• Bachelor’s Degree in Accounting or Finance; CPA required
• 10+ years of relevant experience, including at least 5 years of public accounting and 5 years of public company industry experience, preferably in the biotechnology or diagnostics industry
• Strong technical accounting background with a thorough knowledge of U.S. GAAP, SOX 404, and SEC reporting standards, as well as experience with technical research
• Experience with drafting accounting memos supporting financial statements and footnote disclosures as part of filings with the SEC (10-Q and 10-K)
• Ability to draft original disclosure, MD&A, and other public and private communications
• Experience with assessing and documenting internal controls
• Ability to articulate complex technical issues to both technical and non-technical stakeholders
• Ability to compose, summarize and present material to communicate complex concepts and gain consensus
• Demonstrated ability to independently coordinate multiple priorities in a dynamic environment
• Strong interpersonal and written communication skills enabling effective communications with all levels of management
• Proactive, organized, and takes ownership of projects and deadlines
• Meticulous and superior attention to details
• Solutions-oriented who enjoys solving problems with data analysis and strong execution
• Continuous learning mindset with a passion for improving policies, procedures for compliance, effectiveness, and efficiency
• Quarterly travel to corporate office and as needed

Nice to haves:

• Big 4 firm experience
• Industry experience in diagnostics
• Strong working knowledge of Netsuite

Benefits and additional information:

The US target range of our base salary for new hires is $183,000 - $280,000. You will also be eligible to receive pre-IPO equity, cash bonuses, and a full range of medical, financial, and other benefits depending on the position offered. Please note that individual total compensation for this position will be determined at the Company’s sole discretion and may vary based on several factors, including but not limited to, location, skill level, years and depth of relevant experience, and education. We invite you to check out our career page @ https://careers.freenome.com/ for additional company information.  

Freenome is proud to be an equal-opportunity employer, and we value diversity. Freenome does not discriminate on the basis of race, color, religion, marital status, age, national origin, ancestry, physical or mental disability, medical condition, pregnancy, genetic information, gender, sexual orientation, gender identity or expression, veteran status, or any other status protected under federal, state, or local law.

Applicants have rights under Federal Employment Laws.  

• Family & Medical Leave Act (FMLA)
• Equal Employment Opportunity (EEO)
• Employee Polygraph Protection Act (EPPA)

#LI-Remote